Dr. Refat Sharafedin, Algemene Geneeskund… SRL
Dr. Refat Sharafedin, Algemene Geneeskund… reported total assets of €1.16m at the end of the 2025 financial year (annual accounts filed with the NBB on 26 Oct 2026).
By total assets for 2025, Dr. Refat Sharafedin, Algemene Geneeskund… ranks among the 1,000 largest of the 9,911 companies in its sector (NACE 8621) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Dr. Refat Sharafedin, Algemene Geneeskund… shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +6 % Total assets -3 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Refat Sharafedin, Algemene Geneeskund…'s annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 145,116 € | ||||
| Equity | 678,338 € | ||||
| Cash | 517,775 € | ||||
| EBITDA | 306,911 € | ||||
| Total assets | €1.16m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Oct 2026
- Year ended 31 Dec 2024filed on 31 Oct 2025
- Year ended 31 Dec 2023filed on 04 Nov 2024
- Year ended 31 Dec 2022filed on 18 Sep 2023
- Year ended 31 Dec 2021filed on 03 Oct 2022
Dr. Refat Sharafedin, Algemene Geneeskund…'s financial analysis
- Solvency58.5%sector median: 69.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Refat Sharafedin, Algemene Geneeskund…
1 active director(s) in the register.
Dr. Refat Sharafedin, Algemene Geneeskund…'s shareholders and holdings →Dr. Refat Sharafedin, Algemene Geneeskund…'s publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0836.671.322
- VAT number
- BE0836671322
- Peppol
- Registered · 0208:0836671322 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 31 May 2011
- Registered office
- 1000 Brussels
- Latest accounts
- 2025 · filed on 26 Oct 2026
- Activity
- General medical practice activities (NACE 86210)
Dr. Refat Sharafedin, Algemene Geneeskund… (SRL) has been based in Brussels since 2011, active in: general medical practice activities. For 2025, it reports a net profit of 145,116 € and equity of 678,338 €; its revenue is not published. Its solvency stands at 58.5%, below the median of its sector (69.3%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Refat Sharafedin, Algemene Geneeskund…
Companies in the same business, of comparable size and area, outside its group.
- Dr. A-S de Ghellinck General medical practice activities Beersel · balance sheet €1.19m
- Dokter Ruth Van Pottelbergh Huisarts General medical practice activities Halle · balance sheet €1.16m
- DR. DE MUNTER GREET, huisarts General medical practice activities Lede · balance sheet €1.16m
- Dr. S. Yoshimi General medical practice activities Koekelberg · balance sheet €1.15m
- Dr. Michel Mahieu General medical practice activities Oostkamp · balance sheet €1.13m
- Dokterskabinet Frank De Winter - huisarts General medical practice activities Beveren-Kruibeke-Zwijndrecht · balance sheet €1.16m
- Dr. Omima Ahmed Osman - Huisarts General medical practice activities Ghent · balance sheet €1.16m
- Cabinet Médical KASSIOPÉE General medical practice activities Soignies · balance sheet €1.16m
Frequently asked questions about Dr. Refat Sharafedin, Algemene Geneeskund…
What is the revenue of Dr. Refat Sharafedin, Algemene Geneeskund…?
Dr. Refat Sharafedin, Algemene Geneeskund… files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Refat Sharafedin, Algemene Geneeskund…?
In Belgium, the VAT number is the company number prefixed with BE: BE0836671322 for Dr. Refat Sharafedin, Algemene Geneeskund…, if the company is VAT-registered. Its company number (CBE) is 0836.671.322.
Where is the registered office of Dr. Refat Sharafedin, Algemene Geneeskund…?
According to the CBE register, the registered office of Dr. Refat Sharafedin, Algemene Geneeskund… is in 1000 Brussels.
What is the equity of Dr. Refat Sharafedin, Algemene Geneeskund…?
At the close of the 2025 financial year, the equity of Dr. Refat Sharafedin, Algemene Geneeskund… amounts to 678,338 €, a solvency of 58.5% of total assets.
Who manages Dr. Refat Sharafedin, Algemene Geneeskund…?
The register lists 1 active mandates at Dr. Refat Sharafedin, Algemene Geneeskund…. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Dr. Refat Sharafedin, Algemene Geneeskund… within its sector?
By total assets for 2025, Dr. Refat Sharafedin, Algemene Geneeskund… ranks among the 1,000 largest of the 9,911 companies in its sector (NACE 8621) in Belgium that filed accounts for that financial year.
The full file of Dr. Refat Sharafedin, Algemene Geneeskund…
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →